リソソーム貯蔵障害の有病率
P J Meikle1, J J Hopwood, A E Clague
1Department of Chemical Pathology, Women's and Children's Hospital, Adelaide, Australia. p.meikle@medicine.adelaide.edu.au
JAMA
|January 26, 1999
まとめ
ライソソーム貯蔵障害は個別にまれですが,集団として一般的であり,オーストラリアの出生7700人に1人に影響します. この研究は,それらの集団的流行を定義し,重要な公衆衛生問題を強調しています.
科学分野:
- 医学遺伝学 医学遺伝学
- 珍しい病気 珍しい病気
- エピデミオロジー エピデミオロジー
背景:
- リソソーム貯蔵障害 (LSD) は,41以上の異なる遺伝疾患を網羅しています.
- 個別的には稀ですが,医療システムへの集団的な影響は,実質的ですが,定義が不十分です.
- LSDの集団的流行に関する以前の包括的な研究は不足しています.
研究 の 目的:
- オーストラリアにおけるリソソーム貯蔵障害の個人および集団的流行を確かめるために.
- LSDsによって引き起こされる公衆衛生上の負担の基礎的な理解を確立する.
主な方法:
- 遡及的ケーススタディ分析.
- 1980年から1996年の間にオーストラリアから収集されたデータ.
- 酵素診断は,LSD症例を特定するための主要な結果指標として機能しました.
主要な成果:
- 合計で545人の27種類のLSD患者が診断されました.
- 流行率は,ゴーシャー病 (1:57,000) からシアリドーシス (1:4.2百万) まで,著しく変化しました.
- すべてのLSDの併合的な罹患率は生児1対7700で,グループとして比較的一般的であることを示しています.
結論:
- ライソソーム貯蔵障害は,個別的には稀ですが,オーストラリアでは大きな集団的健康上の懸念となっています.
- 結論は,LSDをグループとして認識して,その全体的な影響に対処することの重要性を強調しています.
さらに関連する動画
10:39Improved Lipofuscin Models and Quantification of Outer Segment Phagocytosis Capacity in Highly Polarized Human Retinal Pigment Epithelial Cultures
Published on: April 14, 2023
05:40Lysosomal Profiling With LysoTracker For Quantitative Assessment of Cellular Senescence In Human Fibroblasts
Published on: July 17, 2026
関連する概念動画
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Delivery Pathways to the Lysosome
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
